mdlinx mdlinx

MDLinx E-mail Article

To email this article, enter your own "From Email" address, the recipient's "To Email" address, and click the "Send Email" button. You may send to up to 5 emails at a time.


* From Email: 
* To Email: 
To Email: 
To Email: 
To Email: 
To Email: 
Email Subject Line: 
Comments:

Risk of tuberculosis reactivation with tofacitinib (cp-690550)

Maiga M et al. – The goal was to characterize the impact of tofacitinib on LTBI using a mouse model of contained TB. The data indicate that tofacitinib reduces host containment of M.tb. and promotes bacterial replication in the lungs, suggesting TB reactivation. Tofacitinib may carry a significant risk for LTBI reactivation in humans. [more...]

Register now to view all the MDLinx contents (FREE)!

  • Stay current on the latest literature, research and clinical news
  • Get special communications and offers from MDLinx and our sponsors
  • Receive invitations to paid market research
View Samples and Register

Stay current - Media Tool

Newsletter
RSS
Follow
Like

Receive the latest mecial news
updates for free via email

Sign up!

Subscribe to our free RSS feeds:

Get the latest news in your specialty automatically added to your newsreader or your personal My Yahoo!, Google, My MSN or My AOL page. Learn More

Close